Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospital Costs | 5 | 2019 | 117 | 2.410 |
Why?
|
| Cardiac Surgical Procedures | 6 | 2019 | 450 | 1.470 |
Why?
|
| Norwood Procedures | 3 | 2017 | 61 | 1.220 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2017 | 138 | 1.100 |
Why?
|
| Heart Defects, Congenital | 3 | 2020 | 596 | 1.020 |
Why?
|
| Airway Extubation | 2 | 2019 | 17 | 0.810 |
Why?
|
| Tetralogy of Fallot | 2 | 2018 | 43 | 0.790 |
Why?
|
| Lost to Follow-Up | 1 | 2020 | 7 | 0.720 |
Why?
|
| Transition to Adult Care | 1 | 2020 | 18 | 0.710 |
Why?
|
| Aortic Coarctation | 1 | 2018 | 37 | 0.640 |
Why?
|
| Postoperative Complications | 5 | 2017 | 1615 | 0.560 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 114 | 0.490 |
Why?
|
| Infant | 7 | 2020 | 2891 | 0.420 |
Why?
|
| Fontan Procedure | 3 | 2022 | 129 | 0.360 |
Why?
|
| Infant, Newborn | 7 | 2018 | 2455 | 0.350 |
Why?
|
| Palliative Care | 3 | 2013 | 271 | 0.340 |
Why?
|
| Academic Medical Centers | 2 | 2011 | 281 | 0.320 |
Why?
|
| Sulfonamides | 2 | 2019 | 141 | 0.300 |
Why?
|
| Pyrimidines | 2 | 2019 | 178 | 0.300 |
Why?
|
| Registries | 2 | 2020 | 733 | 0.280 |
Why?
|
| Length of Stay | 4 | 2017 | 780 | 0.260 |
Why?
|
| Databases, Factual | 3 | 2018 | 622 | 0.260 |
Why?
|
| Retrospective Studies | 5 | 2021 | 7277 | 0.250 |
Why?
|
| Connective Tissue Diseases | 1 | 2023 | 18 | 0.220 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 2 | 2019 | 25 | 0.210 |
Why?
|
| Male | 13 | 2023 | 37321 | 0.210 |
Why?
|
| Humans | 18 | 2023 | 68618 | 0.210 |
Why?
|
| Female | 13 | 2023 | 38074 | 0.210 |
Why?
|
| Myocarditis | 1 | 2021 | 49 | 0.190 |
Why?
|
| Time Factors | 4 | 2021 | 4655 | 0.180 |
Why?
|
| Coronary Aneurysm | 1 | 2020 | 19 | 0.180 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 9 | 0.180 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 20 | 0.180 |
Why?
|
| Cost Savings | 1 | 2020 | 110 | 0.170 |
Why?
|
| Hospital Mortality | 3 | 2015 | 384 | 0.160 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2018 | 17 | 0.160 |
Why?
|
| Disease Management | 1 | 2020 | 248 | 0.160 |
Why?
|
| Regression Analysis | 1 | 2020 | 737 | 0.150 |
Why?
|
| United States | 6 | 2023 | 7367 | 0.150 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 51 | 0.150 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2017 | 7 | 0.150 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2017 | 17 | 0.150 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 34 | 0.150 |
Why?
|
| Postoperative Care | 1 | 2018 | 163 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2019 | 276 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1046 | 0.140 |
Why?
|
| Exercise Therapy | 1 | 2018 | 183 | 0.130 |
Why?
|
| Health Expenditures | 1 | 2018 | 170 | 0.130 |
Why?
|
| Exercise | 2 | 2019 | 658 | 0.130 |
Why?
|
| Research Design | 1 | 2020 | 729 | 0.130 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 73 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2019 | 7029 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 931 | 0.120 |
Why?
|
| Age Factors | 1 | 2018 | 1864 | 0.110 |
Why?
|
| Child | 5 | 2023 | 6405 | 0.110 |
Why?
|
| Adolescent | 3 | 2021 | 8912 | 0.110 |
Why?
|
| Methylprednisolone | 1 | 2013 | 99 | 0.110 |
Why?
|
| Heart Failure | 1 | 2022 | 1180 | 0.110 |
Why?
|
| Hospitalization | 1 | 2018 | 978 | 0.110 |
Why?
|
| Young Adult | 2 | 2021 | 5717 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2020 | 2007 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2800 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 244 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2013 | 222 | 0.100 |
Why?
|
| Hospital Charges | 1 | 2011 | 60 | 0.100 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2013 | 250 | 0.100 |
Why?
|
| Heart Transplantation | 2 | 2011 | 328 | 0.090 |
Why?
|
| Databases as Topic | 1 | 2010 | 49 | 0.090 |
Why?
|
| Cytokines | 1 | 2013 | 866 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 2279 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 546 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2010 | 880 | 0.070 |
Why?
|
| Inflammation | 1 | 2013 | 1030 | 0.070 |
Why?
|
| Logistic Models | 1 | 2010 | 1420 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 567 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2023 | 3187 | 0.060 |
Why?
|
| Risk Factors | 2 | 2013 | 5731 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2019 | 1738 | 0.050 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2021 | 83 | 0.050 |
Why?
|
| Diastole | 1 | 2022 | 161 | 0.050 |
Why?
|
| Vaccination | 1 | 2023 | 189 | 0.050 |
Why?
|
| Models, Economic | 1 | 2020 | 69 | 0.040 |
Why?
|
| Placebo Effect | 1 | 2019 | 20 | 0.040 |
Why?
|
| Markov Chains | 1 | 2020 | 133 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2019 | 101 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2021 | 601 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 586 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 258 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 481 | 0.040 |
Why?
|
| Thrombosis | 1 | 2019 | 218 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2020 | 313 | 0.040 |
Why?
|
| Heart Rate | 1 | 2019 | 568 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2018 | 201 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2018 | 206 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 792 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1054 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 627 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 113 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2013 | 275 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 3259 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 1056 | 0.020 |
Why?
|
| Inpatients | 1 | 2011 | 208 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 504 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 1266 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 1593 | 0.020 |
Why?
|
| South Carolina | 1 | 2013 | 2752 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 3705 | 0.020 |
Why?
|
| Middle Aged | 1 | 2013 | 21147 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 21403 | 0.010 |
Why?
|